Stay updated with breaking news from Incannex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Incannex Healthcare Inc. (IXHL) surged over 45% on Wednesday after the biotechnology company announced positive results from its mid-stage Psi-GAD1 clinical trial of psilocybin for the treatment of generalized anxiety disorder or GAD. ....
MELBOURNE, Australia, May 16, 2023 Incannex Healthcare Ltd is pleased to announce a company presentation which details activities of its psychedelic therapies subsidiary company, called. | May 16, 2023 ....
MELBOURNE, Australia, May 05, 2023 Incannex Healthcare Ltd , a medicinal cannabinoid and psychedelic pharmaceutical development company, is delighted to announce that its subsidiary company,. | May 5, 2023 ....